Zenalb-20

Zenalb-20: properties, application and features

Zenalb-20 is a drug that belongs to the group of plasma replacement solutions based on albumin. The drug is manufactured in the UK by Bio Products Laboratories and is a 20% injection solution.

The composition of the drug includes a polypeptide, which is one of the main protein components of blood serum. The drug is a solution containing 20% ​​albumin.

Indications for use of Zenalb-20 include the treatment of shock (traumatic, surgical and toxic), burns accompanied by dehydration and blood thickening, hypoproteinemia and hypoalbuminemia, gastrointestinal lesions with digestive disorders (peptic ulcer, tumors, difficulties in the patency of the gastrointestinal anastomosis, etc.) .

The drug is contraindicated in cases of thrombosis, severe hypertension, ongoing internal bleeding, and severe forms of heart failure. Restrictions on use arise when cardiac function is depressed, as this can lead to the development of acute heart failure.

When using Zenalb-20, side effects may occur, such as increased body temperature, pain in the lumbar region, and urticaria.

There is no data on the interaction of Zenalb-20 with other drugs. An overdose of the drug has also not been described.

Special instructions apply to the administration of the drug during dehydration, which is possible only after first ensuring sufficient fluid intake (orally, parenterally).

In conclusion, Zenalb-20 is an important drug for the treatment of shock, burns, hypoproteinemia and other conditions accompanied by dehydration and blood thickening. The drug should be used only as prescribed by a doctor, taking into account contraindications and special instructions.